Effects of inhalation of albuterol sulphate, ipratroprium bromide and frusemide on breathing mechanics and gas exchange in healthy exercising horses.
Authors: Bayly W M, Slocombe R F, Schott H C, Hines M T, Sides R H, Hakala J E
Journal: Equine veterinary journal
Summary
# Editorial Summary Researchers sought to determine whether pre-exercise inhalation of common respiratory medications could enhance breathing mechanics and potentially improve performance in healthy horses, given the widespread use of such treatments in equine sport. Seven horses received ipratropium bromide (0.35 μg/kg) 30 minutes before exercise, six received furosemide (1 mg/kg) two hours pre-exercise, and seven received albuterol sulphate (360–720 μg) two hours pre-exercise; each drug was tested independently using crossover protocols, with horses undergoing incremental exercise tests where oxygen consumption, carbon dioxide production, arterial blood gases, airway resistance and nasopharyngeal resistance were measured. Despite rigorous measurement of multiple respiratory parameters, none of the three drugs produced any measurable improvement in breathing mechanics or gas exchange variables across any exercise intensity. The findings suggest that healthy horses mount a sufficient endogenous sympathoadrenergic response during exercise to achieve maximal bronchodilation naturally, rendering exogenous bronchodilators redundant in the absence of underlying respiratory disease. This work has significant implications for competition regulations and pharmaceutical use protocols, indicating that bronchodilator administration to healthy horses lacks physiological or performance-enhancing benefit and should be reserved for animals with documented airway obstruction or inflammatory conditions.
Read the full abstract on PubMed
Practical Takeaways
- •Pre-exercise inhalation of bronchodilators will not improve performance in healthy horses competing at high intensity, as exercise itself maximally dilates airways
- •Resources spent on pre-exercise inhalant medications for sound horses are unlikely to yield competitive advantage and should be directed elsewhere
- •These findings suggest bronchodilators may have application only in horses with underlying airway obstruction or disease, not as performance enhancers in healthy animals
Key Findings
- •Ipratropium bromide (0.35 microg/kg), albuterol sulphate (360-720 microg), and frusemide (1 mg/kg) had no effect on pulmonary resistance, nasopharyngeal resistance, or lower airway resistance in healthy horses during incremental exercise
- •None of the three inhaled drugs affected oxygen consumption, carbon dioxide production, arterial blood gases, heart rate, or any measured breathing mechanics variables
- •Normal sympathoadrenergic response to exercise appears to provide maximal bronchodilation in healthy horses, limiting additional benefit from pharmacological bronchodilators